Related Experiment Videos
Celecoxib for rheumatoid arthritis
S Garner1, D Fidan, R Frankish
1Department of Public Health, St. George's Hospital Medical School, Cranmer Terrace, London, UK, SW17 0RE. sarah.garner@nice.nhs.uk
The Cochrane Database of Systematic Reviews
|January 10, 2003
Summary
Celecoxib effectively manages rheumatoid arthritis (RA) symptoms, similar to traditional NSAIDs, with a potential short-term reduction in gastrointestinal issues. Long-term benefits and risks, especially with aspirin use, require careful consideration due to cost.
Area of Science:
- Rheumatology
- Pharmacology
- Systematic Review
Background:
- Rheumatoid arthritis (RA) is a systemic autoimmune disorder causing joint inflammation.
- Traditional NSAIDs manage RA symptoms but carry significant gastrointestinal risks.
- Selective COX-II inhibitors like celecoxib were developed to mitigate GI toxicity.
Purpose of the Study:
- To systematically review the efficacy and safety of celecoxib for rheumatoid arthritis management.
- To evaluate celecoxib's effectiveness compared to placebo and traditional NSAIDs.
- To assess celecoxib's gastrointestinal safety profile in RA patients.
Main Methods:
- Systematic review of randomized controlled trials (RCTs) published up to August 2002.
- Searched multiple databases including MEDLINE, EMBASE, and Cochrane Library.
- Independent data abstraction and quality assessment of included RCTs.
Main Results:
- Celecoxib demonstrated comparable symptom control to naproxen, diclofenac, and ibuprofen.
- Significantly higher ACR 20 improvement rates observed with celecoxib compared to placebo.
- Short-term data suggest reduced upper GI complications with celecoxib, but long-term data are uncertain.
Conclusions:
- Celecoxib offers comparable efficacy to traditional NSAIDs for RA symptom management.
- Short-term gastrointestinal benefits of celecoxib may not persist long-term.
- The increased cost of celecoxib necessitates balancing potential benefits against long-term uncertainties and risks, especially when co-administered with aspirin.